SCHEMBL30936692

SCHEMBL30936692

CN(C(=O)OC(C)(C)C)c1c(Cl)cccc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.53
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 1/20 0.45
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 2/20 0.38
CCR2 P41597 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
MCL1 Q07820 1/20 0.38
KCNJ6 P48051 1/20 0.37
KCNJ5 P48544 1/20 0.37
KCNJ3 P48549 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936634 0.89 L3MBTL1 (0.46) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL30936704 0.87 MCOLN2 (0.43) MCOLN2ALDH1A1KDM4ECYP3A4CYP2C9
SCHEMBL30936617 0.82 L3MBTL1 (0.42) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL31720691 0.76 MCOLN2 (0.60) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL31720752 0.76 MCOLN2 (0.60) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL31720704 0.74 MCOLN2 (0.57) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL31720716 0.73 MCOLN2 (0.56) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL30936607 0.72 MCOLN2 (0.60) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL31720766 0.72 MCOLN2 (0.54) MCOLN2ALDH1A1KDM4ELMNAHPGD
SCHEMBL23355015 0.71 ALDH1A1 (0.49) MCOLN2ALDH1A1KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 MCOLN2 19/4885ALDH1A1 3137/4885KDM4E 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.